Pulmonx Corporation (LUNG) Tops Q2 EPS by 2c

Pulmonx Corporation (NASDAQ: LUNG) reported Q2 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $23.86 million versus the consensus estimate of $23.47 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Sandisk (SNDK) June 26 weekly calls and puts active, share price down 11.8% into Micron (MU) quarter results
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)